drugset / Trial / NCT02751385

Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer

NCT02751385

Phase 1 Terminated 2 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelOther

Summary

Investigate the effect of multiple oral doses of nintedanib on the single dose kinetics of a combination of ethinylestradiol and levonorgestrel (Microgynon®)

Timeline

Start
2016-05-20
Primary completion
2017-11-28
Completion
2017-11-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule
Subject Nintedanib Small molecule Oral
Subject ethinyl estradiol Small molecule